{"entity":{"type":"insider","cik":"0001273885","url":"/insider/0001273885","json_url":"/insider/0001273885.json","name":"BERGER FRANKLIN M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":60,"n_filings":39,"first":"2008-01-24","last":"2025-01-17","span_basis":"filed_date"},"name_variants":[{"name":"BERGER FRANKLIN M","source":"filing","n_filings":39,"first_seen":"2008-01-24","last_seen":"2025-01-17"}],"transactions":[{"id":9213099,"accession":"0000950170-25-006589","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-006589","line_url":"/filing/0000950170-25-006589#line-2","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Atea Pharmaceuticals, Inc.","issuer_ticker":"AVIR","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":3.3614,"price_display":"3.36","price_state":"stated","total_value":33614.0,"total_display":"33,614.00","total_whole":"33,614","shares_owned_after":476897.0,"shares_owned_after_display":"476,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-16","filed_date":"2025-01-17","scope":"insider"},{"id":4614420,"accession":"0000950170-25-006489","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-25-006489","line_url":"/filing/0000950170-25-006489#line-2","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Atea Pharmaceuticals, Inc.","issuer_ticker":"AVIR","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":3.3614,"price_display":"3.36","price_state":"stated","total_value":33614.0,"total_display":"33,614.00","total_whole":"33,614","shares_owned_after":476897.0,"shares_owned_after_display":"476,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-16","filed_date":"2025-01-17","scope":"insider"},{"id":9213100,"accession":"0000950170-25-006589","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-006589","line_url":"/filing/0000950170-25-006589#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Atea Pharmaceuticals, Inc.","issuer_ticker":"AVIR","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":15000.0,"shares_display":"15,000","price_per_share":3.1923,"price_display":"3.19","price_state":"stated","total_value":47884.5,"total_display":"47,884.50","total_whole":"47,885","shares_owned_after":466897.0,"shares_owned_after_display":"466,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-15","filed_date":"2025-01-17","scope":"insider"},{"id":4614413,"accession":"0000950170-25-006489","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-25-006489","line_url":"/filing/0000950170-25-006489#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Atea Pharmaceuticals, Inc.","issuer_ticker":"AVIR","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15000.0,"shares_display":"15,000","price_per_share":3.1923,"price_display":"3.19","price_state":"stated","total_value":47884.5,"total_display":"47,884.50","total_whole":"47,885","shares_owned_after":466897.0,"shares_owned_after_display":"466,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-01-15","filed_date":"2025-01-17","scope":"insider"},{"id":2551745,"accession":"0000950170-24-135930","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-24-135930","line_url":"/filing/0000950170-24-135930#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Atea Pharmaceuticals, Inc.","issuer_ticker":"AVIR","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":359606.0,"shares_display":"359,606","price_per_share":2.8461,"price_display":"2.85","price_state":"stated","total_value":1023474.6366,"total_display":"1,023,474.64","total_whole":"1,023,475","shares_owned_after":451897.0,"shares_owned_after_display":"451,897","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-12-10","filed_date":"2024-12-12","scope":"insider"},{"id":8599775,"accession":"0000950170-23-065921","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-065921","line_url":"/filing/0000950170-23-065921#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"ESSA Pharma Inc.","issuer_ticker":"EPIX","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23259.0,"shares_display":"23,259","price_per_share":5.73,"price_display":"5.73","price_state":"stated","total_value":133274.07,"total_display":"133,274.07","total_whole":"133,274","shares_owned_after":784404.0,"shares_owned_after_display":"784,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-21","filed_date":"2023-11-22","scope":"insider"},{"id":8621161,"accession":"0000950170-23-064584","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000950170-23-064584","line_url":"/filing/0000950170-23-064584#line-2","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"ESSA Pharma Inc.","issuer_ticker":"EPIX","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16471.0,"shares_display":"16,471","price_per_share":5.99,"price_display":"5.99","price_state":"stated","total_value":98661.29,"total_display":"98,661.29","total_whole":"98,661","shares_owned_after":760875.0,"shares_owned_after_display":"760,875","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-03","filed_date":"2023-11-16","scope":"insider"},{"id":8621159,"accession":"0000950170-23-064584","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950170-23-064584","line_url":"/filing/0000950170-23-064584#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"ESSA Pharma Inc.","issuer_ticker":"EPIX","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":5.35,"price_display":"5.35","price_state":"stated","total_value":321000.0,"total_display":"321,000.00","total_whole":"321,000","shares_owned_after":744404.0,"shares_owned_after_display":"744,404","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-11-02","filed_date":"2023-11-16","scope":"insider"},{"id":8309497,"accession":"0000899243-23-000914","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0000899243-23-000914","line_url":"/filing/0000899243-23-000914","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"ESSA Pharma Inc.","issuer_ticker":"EPIX","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72223.0,"shares_display":"72,223","price_per_share":2.4147538872658294,"price_display":"2.41","price_state":"stated","total_value":174400.77,"total_display":"174,400.77","total_whole":"174,401","shares_owned_after":718738.0,"shares_owned_after_display":"718,738","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-21","filed_date":"2023-01-05","scope":"insider","n_lines":2},{"id":8309494,"accession":"0000899243-23-000914","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000899243-23-000914","line_url":"/filing/0000899243-23-000914#line-5","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"ESSA Pharma Inc.","issuer_ticker":"EPIX","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43617.0,"shares_display":"43,617","price_per_share":2.53,"price_display":"2.53","price_state":"stated","total_value":110351.01,"total_display":"110,351.01","total_whole":"110,351","shares_owned_after":756627.0,"shares_owned_after_display":"756,627","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-20","filed_date":"2023-01-05","scope":"insider"},{"id":8309491,"accession":"0000899243-23-000914","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-23-000914","line_url":"/filing/0000899243-23-000914#line-4","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"ESSA Pharma Inc.","issuer_ticker":"EPIX","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":2.67,"price_display":"2.67","price_state":"stated","total_value":133500.0,"total_display":"133,500.00","total_whole":"133,500","shares_owned_after":800244.0,"shares_owned_after_display":"800,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-16","filed_date":"2023-01-05","scope":"insider"},{"id":8309489,"accession":"0000899243-23-000914","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000899243-23-000914","line_url":"/filing/0000899243-23-000914","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"ESSA Pharma Inc.","issuer_ticker":"EPIX","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":82000.0,"shares_display":"82,000","price_per_share":2.875609756097561,"price_display":"2.88","price_state":"stated","total_value":235800.0,"total_display":"235,800.00","total_whole":"235,800","shares_owned_after":850244.0,"shares_owned_after_display":"850,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2023-01-05","scope":"insider","n_lines":2},{"id":8309484,"accession":"0000899243-23-000914","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-23-000914","line_url":"/filing/0000899243-23-000914#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"ESSA Pharma Inc.","issuer_ticker":"EPIX","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":3.0,"price_display":"3.00","price_state":"stated","total_value":75000.0,"total_display":"75,000.00","total_whole":"75,000","shares_owned_after":932244.0,"shares_owned_after_display":"932,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-12-14","filed_date":"2023-01-05","scope":"insider"},{"id":6961769,"accession":"0001104659-22-121849","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-22-121849","line_url":"/filing/0001104659-22-121849#line-2","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Rain Therapeutics Inc.","issuer_ticker":"RAIN","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":77000.0,"shares_display":"77,000","price_per_share":8.27,"price_display":"8.27","price_state":"stated","total_value":636790.0,"total_display":"636,790.00","total_whole":"636,790","shares_owned_after":1005207.0,"shares_owned_after_display":"1,005,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-22","filed_date":"2022-11-23","scope":"insider"},{"id":6961766,"accession":"0001104659-22-121849","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-121849","line_url":"/filing/0001104659-22-121849#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Rain Therapeutics Inc.","issuer_ticker":"RAIN","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":45000.0,"shares_display":"45,000","price_per_share":7.8,"price_display":"7.80","price_state":"stated","total_value":351000.0,"total_display":"351,000.00","total_whole":"351,000","shares_owned_after":928207.0,"shares_owned_after_display":"928,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-21","filed_date":"2022-11-23","scope":"insider"},{"id":6444218,"accession":"0000899243-22-035942","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-22-035942","line_url":"/filing/0000899243-22-035942#line-2","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Atea Pharmaceuticals, Inc.","issuer_ticker":"AVIR","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16166.0,"shares_display":"16,166","price_per_share":5.156,"price_display":"5.16","price_state":"stated","total_value":83351.896,"total_display":"83,351.90","total_whole":"83,352","shares_owned_after":778353.0,"shares_owned_after_display":"778,353","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-14","filed_date":"2022-11-15","scope":"insider"},{"id":6444212,"accession":"0000899243-22-035942","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-035942","line_url":"/filing/0000899243-22-035942#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Atea Pharmaceuticals, Inc.","issuer_ticker":"AVIR","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25500.0,"shares_display":"25,500","price_per_share":5.1503,"price_display":"5.15","price_state":"stated","total_value":131332.65,"total_display":"131,332.65","total_whole":"131,333","shares_owned_after":794519.0,"shares_owned_after_display":"794,519","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-11","filed_date":"2022-11-15","scope":"insider"},{"id":6645769,"accession":"0000899243-22-035691","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-22-035691","line_url":"/filing/0000899243-22-035691#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Rain Therapeutics Inc.","issuer_ticker":"RAIN","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":42881.0,"shares_display":"42,881","price_per_share":5.83,"price_display":"5.83","price_state":"stated","total_value":249996.23,"total_display":"249,996.23","total_whole":"249,996","shares_owned_after":883207.0,"shares_owned_after_display":"883,207","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-11-08","filed_date":"2022-11-14","scope":"insider"},{"id":6329046,"accession":"0001209191-22-020584","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-020584","line_url":"/filing/0001209191-22-020584#line-3","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":14.77,"price_display":"14.77","price_state":"stated","total_value":295400.0,"total_display":"295,400.00","total_whole":"295,400","shares_owned_after":890691.0,"shares_owned_after_display":"890,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-21","filed_date":"2022-03-22","scope":"insider"},{"id":6329043,"accession":"0001209191-22-020584","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-22-020584","line_url":"/filing/0001209191-22-020584","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":16.74,"price_display":"16.74","price_state":"stated","total_value":1004400.0,"total_display":"1,004,400.00","total_whole":"1,004,400","shares_owned_after":870691.0,"shares_owned_after_display":"870,691","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-03-18","filed_date":"2022-03-22","scope":"insider","n_lines":2},{"id":5133206,"accession":"0000899243-21-037351","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-21-037351","line_url":"/filing/0000899243-21-037351#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Rain Therapeutics Inc.","issuer_ticker":"RAIN","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3786.0,"shares_display":"3,786","price_per_share":14.3,"price_display":"14.30","price_state":"stated","total_value":54139.8,"total_display":"54,139.80","total_whole":"54,140","shares_owned_after":840326.0,"shares_owned_after_display":"840,326","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-21","filed_date":"2021-09-23","scope":"insider"},{"id":5030652,"accession":"0000899243-21-017113","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-21-017113","line_url":"/filing/0000899243-21-017113","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Rain Therapeutics Inc.","issuer_ticker":"RAIN","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":125000.0,"shares_display":"125,000","price_per_share":16.9512,"price_display":"16.95","price_state":"stated","total_value":2118900.0,"total_display":"2,118,900.00","total_whole":"2,118,900","shares_owned_after":120000.0,"shares_owned_after_display":"120,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-23","filed_date":"2021-04-27","scope":"insider","n_lines":2},{"id":5394841,"accession":"0001209191-21-017990","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-017990","line_url":"/filing/0001209191-21-017990#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"ESSA Pharma Inc.","issuer_ticker":"EPIX","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":57000.0,"shares_display":"57,000","price_per_share":27.0,"price_display":"27.00","price_state":"stated","total_value":1539000.0,"total_display":"1,539,000.00","total_whole":"1,539,000","shares_owned_after":957244.0,"shares_owned_after_display":"957,244","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-02-22","filed_date":"2021-03-04","scope":"insider"},{"id":2553263,"accession":"0000899243-20-030331","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-20-030331","line_url":"/filing/0000899243-20-030331#line-2","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Atea Pharmaceuticals, Inc.","issuer_ticker":"AVIR","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":41666.0,"shares_display":"41,666","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":999984.0,"total_display":"999,984.00","total_whole":"999,984","shares_owned_after":820019.0,"shares_owned_after_display":"820,019","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-11-03","filed_date":"2020-11-03","scope":"insider"},{"id":2510251,"accession":"0001209191-20-036045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-036045","line_url":"/filing/0001209191-20-036045#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100000.0,"shares_display":"100,000","price_per_share":5.5,"price_display":"5.50","price_state":"stated","total_value":550000.0,"total_display":"550,000.00","total_whole":"550,000","shares_owned_after":784003.0,"shares_owned_after_display":"784,003","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-11","filed_date":"2020-06-11","scope":"insider"},{"id":2066125,"accession":"0001209191-20-007050","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-007050","line_url":"/filing/0001209191-20-007050#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":120846.0,"shares_display":"120,846","price_per_share":2.6,"price_display":"2.60","price_state":"stated","total_value":314199.6,"total_display":"314,199.60","total_whole":"314,200","shares_owned_after":684003.0,"shares_owned_after_display":"684,003","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-04","filed_date":"2020-02-05","scope":"insider"},{"id":8011233,"accession":"0001209191-19-059155","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-059155","line_url":"/filing/0001209191-19-059155#line-2","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS, INC.","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47890.0,"shares_display":"47,890","price_per_share":4.0,"price_display":"4.00","price_state":"stated","total_value":191560.0,"total_display":"191,560.00","total_whole":"191,560","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-03","filed_date":"2019-12-04","scope":"insider"},{"id":8011229,"accession":"0001209191-19-059155","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-059155","line_url":"/filing/0001209191-19-059155#line-1","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS, INC.","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32090.0,"shares_display":"32,090","price_per_share":3.92,"price_display":"3.92","price_state":"stated","total_value":125792.8,"total_display":"125,792.80","total_whole":"125,793","shares_owned_after":52890.0,"shares_owned_after_display":"52,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-02","filed_date":"2019-12-04","scope":"insider"},{"id":6524141,"accession":"0001209191-18-056298","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-056298","line_url":"/filing/0001209191-18-056298#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":40000.0,"shares_display":"40,000","price_per_share":6.75,"price_display":"6.75","price_state":"stated","total_value":270000.0,"total_display":"270,000.00","total_whole":"270,000","shares_owned_after":40000.0,"shares_owned_after_display":"40,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-10-26","filed_date":"2018-10-26","scope":"insider"},{"id":6605382,"accession":"0001209191-18-039668","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-18-039668","line_url":"/filing/0001209191-18-039668#line-3","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Kezar Life Sciences, Inc.","issuer_ticker":"KZR","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50000.0,"shares_display":"50,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":750000.0,"total_display":"750,000.00","total_whole":"750,000","shares_owned_after":563157.0,"shares_owned_after_display":"563,157","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-25","filed_date":"2018-06-27","scope":"insider"},{"id":5255981,"accession":"0001209191-17-066244","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-066244","line_url":"/filing/0001209191-17-066244#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":60000.0,"shares_display":"60,000","price_per_share":5.0,"price_display":"5.00","price_state":"stated","total_value":300000.0,"total_display":"300,000.00","total_whole":"300,000","shares_owned_after":266162.0,"shares_owned_after_display":"266,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-18","filed_date":"2017-12-19","scope":"insider"},{"id":4630783,"accession":"0001209191-17-058672","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-058672","line_url":"/filing/0001209191-17-058672#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Immune Design Corp.","issuer_ticker":"IMDZ","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":4.575,"price_display":"4.58","price_state":"stated","total_value":114375.0,"total_display":"114,375.00","total_whole":"114,375","shares_owned_after":75000.0,"shares_owned_after_display":"75,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-30","filed_date":"2017-11-01","scope":"insider"},{"id":5353599,"accession":"0001209191-17-058081","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-058081","line_url":"/filing/0001209191-17-058081#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Immune Design Corp.","issuer_ticker":"IMDZ","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":4.2648,"price_display":"4.26","price_state":"stated","total_value":106620.0,"total_display":"106,620.00","total_whole":"106,620","shares_owned_after":50000.0,"shares_owned_after_display":"50,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-10-25","filed_date":"2017-10-26","scope":"insider"},{"id":2502041,"accession":"0000899243-16-035955","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-035955","line_url":"/filing/0000899243-16-035955#line-2","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":14000.0,"shares_display":"14,000","price_per_share":11.5244,"price_display":"11.52","price_state":"stated","total_value":161341.6,"total_display":"161,341.60","total_whole":"161,342","shares_owned_after":206162.0,"shares_owned_after_display":"206,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-16","filed_date":"2016-12-19","scope":"insider"},{"id":2141973,"accession":"0001209191-16-156169","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-156169","line_url":"/filing/0001209191-16-156169#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Immune Design Corp.","issuer_ticker":"IMDZ","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50000.0,"shares_display":"50,000","price_per_share":6.5466,"price_display":"6.55","price_state":"stated","total_value":327330.0,"total_display":"327,330.00","total_whole":"327,330","shares_owned_after":25000.0,"shares_owned_after_display":"25,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-16","filed_date":"2016-12-20","scope":"insider"},{"id":2502038,"accession":"0000899243-16-035955","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-035955","line_url":"/filing/0000899243-16-035955#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":26000.0,"shares_display":"26,000","price_per_share":10.9856,"price_display":"10.99","price_state":"stated","total_value":285625.6,"total_display":"285,625.60","total_whole":"285,626","shares_owned_after":192162.0,"shares_owned_after_display":"192,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-15","filed_date":"2016-12-19","scope":"insider"},{"id":2942778,"accession":"0000899243-16-029029","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-16-029029","line_url":"/filing/0000899243-16-029029#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":69230.0,"shares_display":"69,230","price_per_share":13.0,"price_display":"13.00","price_state":"stated","total_value":899990.0,"total_display":"899,990.00","total_whole":"899,990","shares_owned_after":166162.0,"shares_owned_after_display":"166,162","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-14","filed_date":"2016-09-15","scope":"insider"},{"id":2413166,"accession":"0001209191-16-115782","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-115782","line_url":"/filing/0001209191-16-115782","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":49.468,"price_display":"49.47","price_state":"stated","total_value":247340.0,"total_display":"247,340.00","total_whole":"247,340","shares_owned_after":84980.0,"shares_owned_after_display":"84,980","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-22","filed_date":"2016-04-26","scope":"insider","n_lines":2},{"id":2549041,"accession":"0001209191-16-115112","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-115112","line_url":"/filing/0001209191-16-115112","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6090.0,"shares_display":"6,090","price_per_share":47.06183908045977,"price_display":"47.06","price_state":"stated","total_value":286606.6,"total_display":"286,606.60","total_whole":"286,607","shares_owned_after":77890.0,"shares_owned_after_display":"77,890","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-04-19","filed_date":"2016-04-21","scope":"insider","n_lines":2},{"id":3106915,"accession":"0000899243-16-013609","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-16-013609","line_url":"/filing/0000899243-16-013609#line-2","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"PROTEOSTASIS THERAPEUTICS, INC.","issuer_ticker":"PTI","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":8.0,"price_display":"8.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":96932.0,"shares_owned_after_display":"96,932","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-02-17","filed_date":"2016-02-17","scope":"insider"},{"id":8519283,"accession":"0001123292-15-000715","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-15-000715","line_url":"/filing/0001123292-15-000715#line-1","is_derivative":false,"issuer_cik":"0001273885","issuer_name":"Immune Design Corp.","issuer_ticker":"IMDZ","issuer_name_source":null,"issuer_url":"/issuer/0001273885","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":26.5,"price_display":"26.50","price_state":"stated","total_value":662500.0,"total_display":"662,500.00","total_whole":"662,500","shares_owned_after":75000.0,"shares_owned_after_display":"75,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-04-21","filed_date":"2015-04-21","scope":"insider"},{"id":8879478,"accession":"0001123292-15-000224","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-15-000224","line_url":"/filing/0001123292-15-000224#line-1","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":27.03,"price_display":"27.03","price_state":"stated","total_value":675750.0,"total_display":"675,750.00","total_whole":"675,750","shares_owned_after":37000.0,"shares_owned_after_display":"37,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-28","filed_date":"2015-01-29","scope":"insider"},{"id":8357752,"accession":"0001123292-15-000166","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001123292-15-000166","line_url":"/filing/0001123292-15-000166#line-2","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5049.0,"shares_display":"5,049","price_per_share":25.7606,"price_display":"25.76","price_state":"stated","total_value":130065.2694,"total_display":"130,065.27","total_whole":"130,065","shares_owned_after":12000.0,"shares_owned_after_display":"12,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-15","filed_date":"2015-01-16","scope":"insider"},{"id":8357746,"accession":"0001123292-15-000166","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001123292-15-000166","line_url":"/filing/0001123292-15-000166#line-1","is_derivative":false,"issuer_cik":"0001175505","issuer_name":"FIVE PRIME THERAPEUTICS INC","issuer_ticker":"FPRX","issuer_name_source":null,"issuer_url":"/issuer/0001175505","owner_cik":"0001273885","owner_name":"BERGER FRANKLIN M","owner_display_name":"BERGER FRANKLIN M","owner_url":"/insider/0001273885","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":26.5775,"price_display":"26.58","price_state":"stated","total_value":132887.5,"total_display":"132,887.50","total_whole":"132,888","shares_owned_after":6951.0,"shares_owned_after_display":"6,951","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-01-14","filed_date":"2015-01-16","scope":"insider"}],"collapsed":true,"next_cursor":"2015-01-14|8357746","ledger_fault":false,"count":{"value":60,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":47,"open_market":true},{"code":"S","label":"Open-market sale","n":13,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":60},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001593899","name":"Atea Pharmaceuticals, Inc.","url":"/issuer/0001593899","role":"Director","n_filings":5,"first_seen":"2020-11-03","last_seen":"2025-01-17"},{"type":"issuer","type_label":"ISSUER","cik":"0001633932","name":"ESSA Pharma Inc.","url":"/issuer/0001633932","role":"Director","n_filings":4,"first_seen":"2021-03-04","last_seen":"2023-11-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001724979","name":"Rain Therapeutics Inc.","url":"/issuer/0001724979","role":"Director","n_filings":4,"first_seen":"2021-04-27","last_seen":"2022-11-23"},{"type":"issuer","type_label":"ISSUER","cik":"0001645666","name":"Kezar Life Sciences, Inc.","url":"/issuer/0001645666","role":"Director","n_filings":4,"first_seen":"2018-06-27","last_seen":"2022-03-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001175505","name":"FIVE PRIME THERAPEUTICS, INC.","url":"/issuer/0001175505","role":"Director","n_filings":6,"first_seen":"2014-12-02","last_seen":"2019-12-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001445283","name":"PROTEOSTASIS THERAPEUTICS, INC.","url":"/issuer/0001445283","role":"Director","n_filings":5,"first_seen":"2016-02-17","last_seen":"2018-10-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001437786","name":"Immune Design Corp.","url":"/issuer/0001437786","role":"Director","n_filings":5,"first_seen":"2014-07-31","last_seen":"2017-11-01"},{"type":"issuer","type_label":"ISSUER","cik":"0000876343","name":"BIOTIME INC","url":"/issuer/0000876343","role":"Director","n_filings":1,"first_seen":"2013-08-22","last_seen":"2013-08-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001060736","name":"SEATTLE GENETICS INC /WA","url":"/issuer/0001060736","role":"Director","n_filings":5,"first_seen":"2008-01-24","last_seen":"2011-06-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001273885","retrieved_at":"2026-08-25T10:06:44+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-24","last_ingest":"2026-08-25T05:24:19.374141+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}